Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
4.995
-0.215 (-4.13%)
May 18, 2026, 2:25 PM EDT - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $818.39 million as of May 18, 2026. Its market cap has increased by 302.12% in one year.
Market Cap
818.39M
Enterprise Value
613.89M
1-Year Change
302.12%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $818.39M, an increase of 27.97%. That is a compound annual growth rate of 4.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 853.62M | 14.08% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 870.53M |
| Sana Biotechnology | 854.36M |
| LB Pharmaceuticals | 850.55M |
| Janux Therapeutics | 847.07M |
| ORIC Pharmaceuticals | 843.67M |
| Arbutus Biopharma | 837.56M |
| Theravance Biopharma | 836.19M |
| Xencor | 831.87M |